| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311686 | Urology | 2005 | 5 Pages |
Abstract
The results of this brachytherapy investigation with the longest reported follow-up period to date suggest that statins, especially atorvastatin, may improve most clinical presentations with a nonsignificant improvement in 8-year biochemical progression-free survival.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mark A. Moyad, Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Robert W. Galbreath, Brian Kurko, Edward Adamovich,